STRATA Skin Sciences announced that the Company will be presenting a poster titled “Pulsed Broadband Light with Vacuum Suction and Needle Insert to Treat Acne” at the Maui Derm 2024 Meeting to be held at the Grand Wailea in Maui, Hawaii from January 22-26, 2024. The poster highlights the safety and efficacy of one treatment session using STRATA’s TheraClear X technology for cystic and papular acne reduction. TheraClear X uses Photopneumatic technology that delivers intense pulsed light utilizing vacuum technology with an additional needle insert; the vacuum pulls the tissue into the needle, penetrating the acne lesion and thereby creating a pathway for sebum extraction. Majority of lesions demonstrated greater than or equal to50% clearing by 1-2 weeks, exceeding the criteria of greater than or equal to30% reduction in lesion size at two follow-up visits. An average reduction in lesion size was rated 2.0 at 24-72 hours post-treatment and 3.5 at 1-2 weeks. At 1-2 weeks, the most frequently reported event was mild hyperpigmentation; erythema, edema, and flaking were observed in less than or equal to10% of lesions.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SSKN:
- Strata Skin Sciences granted extension by Nasdaq to regain compliance
- STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech
- Strata Skin Sciences expands distribution agreement with Kosmo Meditech
- Strata Skin Sciences promotes Gov to Chief Operating Officer
- STRATA Skin Science Announces Strengthening of Leadership Team